Top compounds associated with response to LRTM2


Feature Type Standardized
Nominal ANOVA
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.15 0.002
mRNA paclitaxel UHNBreast pan-cancer AAC -0.8 0.002
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.099 0.002
mRNA CIL70 CTRPv2 pan-cancer AAC 0.15 0.003
Download CSV